Nucleus Speciality Pharma Llp

Nucleus Speciality Pharma Llp - home appliances in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
LLPIN ABC-1401 Incorporated 19 August 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership home appliances
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
4 yrs
Est. 2022
Last financials
Mar 2023
Balance sheet date

About Nucleus Speciality Pharma Llp

Data last updated: 14 February 2026

Nucleus Speciality Pharma Llp is a limited liability partnership company based in Mumbai, Maharashtra, India. It specialises in retail trade, a part of the broader home appliances and consumer durables sector. Incorporated on 19 August 2022.

Registered with ROC Mumbai under LLPIN ABC-1401.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Sandeep Udaypratap Singh and Kishore Atmaram Wadekar.

Accounts filed on 31 March 2023. Office: A – 603 Girnar Tower G D Ambekar Marg, Ambewadi Kalachowki Mumbai, Maharashtra, India – 400033.

Company Details of Nucleus Speciality Pharma Llp
LLPIN ABC-1401
Incorporation Date 19 August 2022
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Active
Date of Last AGM 31 March 2023
Date of Balance Sheet 31 March 2023
Key People
Sandeep Udaypratap Singh Designated Partner Kishore Atmaram Wadekar Designated Partner Mahendra Hukumsingh Rajpurohit Designated Partner
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    A – 603 Girnar Tower G D Ambekar Marg, Ambewadi Kalachowki Mumbai, Maharashtra, India – 400033
  • Industry
    Home Appliances, Retailers, Maintenance Services (Repair), Consumer Goods (Retail)
Company report
Nucleus Speciality Pharma Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nucleus Speciality Pharma Llp report

Financials, compliance, directors, charges, ownership and filings for Nucleus Speciality Pharma Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Nucleus Speciality Pharma Llp

Nucleus Speciality Pharma Llp is governed by 3 designated partners who oversee the company's operations and strategic decisions.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Sandeep Udaypratap Singh Designated Partner 19 Aug 2022 3 Years 10 Months Current
Kishore Atmaram Wadekar Designated Partner 19 Aug 2022 3 Years 10 Months Current
Mahendra Hukumsingh Rajpurohit
Also directs: Om Shanti Infrastructure Realty Llp, Sarika Real Infra Llp
Designated Partner 19 Aug 2022 3 Years 10 Months Current
View all designated partners

Financials of Nucleus Speciality Pharma Llp FY 2023 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Nucleus Speciality Pharma Llp

Nucleus Speciality Pharma Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Nucleus Speciality Pharma Llp

View historical data on people associated with Nucleus Speciality Pharma Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Nucleus Speciality Pharma Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Nucleus Speciality Pharma Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Nucleus Speciality Pharma Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Nucleus Speciality Pharma Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Nucleus Speciality Pharma Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Nucleus Speciality Pharma Llp

MSME Payment Delays by Nucleus Speciality Pharma Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Nucleus Speciality Pharma Llp

Subsidiaries & Group Companies of Nucleus Speciality Pharma Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Nucleus Speciality Pharma Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Nucleus Speciality Pharma Llp

MCA Filings & Documents of Nucleus Speciality Pharma Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Nucleus Speciality Pharma Llp

Activity
31 Mar 2023
Nucleus Speciality Pharma Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Activity
31 Mar 2023
Nucleus Speciality Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Directors
19 Aug 2022
Sandeep Udaypratap Singh was appointed as a Designated Partner on 19 Aug 2022 & has been associated with this company since 3 years 10 months.
Directors
19 Aug 2022
Kishore Atmaram Wadekar was appointed as a Designated Partner on 19 Aug 2022 & has been associated with this company since 3 years 10 months.
Directors
19 Aug 2022
Mahendra Hukumsingh Rajpurohit was appointed as a Designated Partner on 19 Aug 2022 & has been associated with this company since 3 years 10 months.
Activity
19 Aug 2022
Nucleus Speciality Pharma Llp was registered on 19 Aug 2022 with Roc Mumbai & aged 3 years 10 months as per MCA records.

Frequently Asked Questions about Nucleus Speciality Pharma Llp

Nucleus Speciality Pharma Llp is an active limited liability partnership in the home appliances sector based in Mumbai, Maharashtra, India. It was incorporated on 19 August 2022 (4+ years old) and is registered under LLPIN ABC-1401.

The current designated partners of Nucleus Speciality Pharma Llp are:

The primary industry of Nucleus Speciality Pharma Llp is home appliances. The LLP specifically operates in retailers. The LLP is currently active in this sector.

Nucleus Speciality Pharma Llp can be reached at the registered office: A – 603 Girnar Tower G D Ambekar Marg, Ambewadi Kalachowki Mumbai, Maharashtra, India – 400033.

The total obligation of contribution is ₹1 Lakh.

The LLP has its registered office at A – 603 Girnar Tower G D Ambekar Marg, Ambewadi Kalachowki Mumbai, Maharashtra, India – 400033.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available